Free Trial

Yield10 Bioscience Q1 2023 Earnings Report

Yield10 Bioscience logo
$0.02 0.00 (0.00%)
As of 02/20/2025

Yield10 Bioscience EPS Results

Actual EPS
-$18.24
Consensus EPS
-$10.80
Beat/Miss
Missed by -$7.44
One Year Ago EPS
N/A

Yield10 Bioscience Revenue Results

Actual Revenue
$0.06 million
Expected Revenue
$0.06 million
Beat/Miss
Met Expectations
YoY Revenue Growth
N/A

Yield10 Bioscience Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Yield10 Bioscience Earnings Headlines

Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
See More Yield10 Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Yield10 Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Yield10 Bioscience and other key companies, straight to your email.

About Yield10 Bioscience

Yield10 Bioscience (NASDAQ:YTEN) operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

View Yield10 Bioscience Profile

More Earnings Resources from MarketBeat